• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

聚乙二醇干扰素 α-2a/利巴韦林治疗丙型肝炎患者时,血清 HCV RNA 优化阈值预测治疗结局。

Optimized threshold for serum HCV RNA to predict treatment outcomes in hepatitis C patients receiving peginterferon alfa-2a/ribavirin.

机构信息

Johann Wolfgang Goethe University Medical Center, Frankfurt am Main, Germany.

出版信息

J Viral Hepat. 2012 Nov;19(11):766-74. doi: 10.1111/j.1365-2893.2012.01624.x. Epub 2012 May 14.

DOI:10.1111/j.1365-2893.2012.01624.x
PMID:23043383
Abstract

It is unclear whether the current threshold for 'high' hepatitis C virus (HCV) RNA level (800,000 IU/mL) is optimal for predicting sustained virological response (SVR). We retrospectively analysed pretreatment HCV RNA levels and SVR rates in 1529 mono-infected and 176 HIV-HCV co-infected patients treated with peginterferon alfa-2a (40 kD) plus ribavirin. We improved the threshold for differentiating low and high viral load by fitting semiparametric generalized additive logistic regression models to the data and constructing receiver operating characteristics curves. Among HCV genotype 1 mono-infected patients, the difference in SVR rates between those with low and high baseline HCV RNA levels was 27% (70%vs 43%) when 400,000 IU/mL was used and 16% (59%vs 43%) when 800,000 IU/mL was used. In HIV-HCV genotype 1 co-infected patients, the difference was 51% (71%vs 20%) when 400,000 IU/mL was used and 43% (61%vs 18%) when 800,000 IU/mL was used. A lower threshold (200,000 IU/mL) was identified for genotype 1 mono-infected patients with 'normal' alanine aminotransferase (ALT) levels. No threshold could be identified in HCV genotype 2 or 3 patients. A threshold HCV RNA level of 400,000 IU/mL is optimal for differentiating high and low probability of SVR in genotype 1-infected individuals with elevated ALT.

摘要

目前,对于预测持续病毒学应答(SVR),丙型肝炎病毒(HCV)RNA 水平的“高”阈值(80 万 IU/mL)是否最佳尚不清楚。我们回顾性分析了接受聚乙二醇干扰素 alfa-2a(40kD)联合利巴韦林治疗的 1529 例单纯感染和 176 例 HIV-HCV 合并感染患者的治疗前 HCV RNA 水平和 SVR 率。我们通过拟合半参数广义加性逻辑回归模型对数据进行分析,并构建受试者工作特征曲线,改进了区分低病毒载量和高病毒载量的阈值。在 HCV 基因型 1 单纯感染患者中,当使用 40 万 IU/mL 时,低基线 HCV RNA 水平和高基线 HCV RNA 水平患者的 SVR 率差异为 27%(70% vs 43%),当使用 80 万 IU/mL 时,SVR 率差异为 16%(59% vs 43%)。在 HIV-HCV 基因型 1 合并感染患者中,当使用 40 万 IU/mL 时,SVR 率差异为 51%(71% vs 20%),当使用 80 万 IU/mL 时,SVR 率差异为 43%(61% vs 18%)。对于丙氨酸氨基转移酶(ALT)水平“正常”的基因型 1 单纯感染患者,确定了较低的阈值(20 万 IU/mL)。在 HCV 基因型 2 或 3 患者中无法确定阈值。对于 ALT 升高的基因型 1 感染者,40 万 IU/mL 的 HCV RNA 水平阈值是区分 SVR 高概率和低概率的最佳选择。

相似文献

1
Optimized threshold for serum HCV RNA to predict treatment outcomes in hepatitis C patients receiving peginterferon alfa-2a/ribavirin.聚乙二醇干扰素 α-2a/利巴韦林治疗丙型肝炎患者时,血清 HCV RNA 优化阈值预测治疗结局。
J Viral Hepat. 2012 Nov;19(11):766-74. doi: 10.1111/j.1365-2893.2012.01624.x. Epub 2012 May 14.
2
Intensified peginterferon α-2a dosing increases sustained virologic response rates in heavy, high viral load hepatitis C genotype 1 patients with high low-density lipoprotein.强化聚乙二醇干扰素 α-2a 给药可提高高病毒载量丙型肝炎基因型 1 且伴有高低密度脂蛋白血症的重度患者的持续病毒学应答率。
J Clin Gastroenterol. 2013 Mar;47(3):271-9. doi: 10.1097/MCG.0b013e31826102eb.
3
Peginterferon alfa-2a and peginterferon alfa-2b combined with ribavirin in patients with genotype 1 chronic hepatitis C: results of a prospective single-centre study.聚乙二醇干扰素 alfa-2a 和聚乙二醇干扰素 alfa-2b 联合利巴韦林治疗基因 1 型慢性丙型肝炎患者:一项前瞻性单中心研究的结果。
Adv Med Sci. 2014 Sep;59(2):261-5. doi: 10.1016/j.advms.2014.01.005. Epub 2014 Jun 9.
4
Peginterferon alpha-2a and ribavirin in patients with hepatitis C virus genotype 1 infection with persistently normal alanine aminotransferase levels.聚乙二醇干扰素 alpha-2a 和利巴韦林治疗丙型肝炎病毒基因型 1 感染伴持续正常丙氨酸氨基转移酶水平的患者。
J Gastroenterol Hepatol. 2012 Nov;27(11):1705-10. doi: 10.1111/j.1440-1746.2012.07214.x.
5
Rapid virological response as a predictor of sustained response in HCV-infected patients with persistently normal alanine aminotransferase levels: A multicenter study.持续正常丙氨酸氨基转移酶水平的 HCV 感染患者中快速病毒学应答可预测持续应答:一项多中心研究。
J Viral Hepat. 2011 Jun;18(6):393-9. doi: 10.1111/j.1365-2893.2010.01319.x.
6
Early HCV RNA changes in patients with chronic hepatitis C treated with peginterferon alfa 2b and ribavirin.接受聚乙二醇干扰素α-2b和利巴韦林治疗的慢性丙型肝炎患者早期丙型肝炎病毒RNA变化
Rev Invest Clin. 2003 Mar-Apr;55(2):138-42.
7
Undetectable hepatitis C virus RNA at week 4 as predictor of sustained virological response in HIV patients with chronic hepatitis C.第4周丙型肝炎病毒RNA检测不到作为慢性丙型肝炎合并HIV患者持续病毒学应答的预测指标
AIDS. 2008 Jan 2;22(1):15-21. doi: 10.1097/QAD.0b013e3282f1da99.
8
A tool for selecting patients with a high probability of sustained virological response to peginterferon alfa-2a (40kD)/ribavirin.一种用于筛选对聚乙二醇干扰素α-2a(40kD)/利巴韦林有高持续病毒学应答概率患者的工具。
Liver Int. 2014 Nov;34(10):1550-9. doi: 10.1111/liv.12439. Epub 2014 Jan 9.
9
Plasma HCV-RNA decline in the first 48 h identifies hepatitis C virus mono-infected but not HCV/HIV-coinfected patients with an undetectable HCV viral load at week 4 of peginterferon-alfa-2a/ribavirin therapy.在聚乙二醇干扰素-α-2a/利巴韦林治疗的第 4 周时,若患者在最初 48 小时内的血浆 HCV-RNA 下降,则可确定其为单纯丙型肝炎病毒感染,而非丙型肝炎病毒/人类免疫缺陷病毒合并感染,且其 HCV 病毒载量无法检测到。
J Viral Hepat. 2009 Dec;16(12):867-75. doi: 10.1111/j.1365-2893.2009.01143.x. Epub 2009 May 11.
10
Peginterferon Alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients.聚乙二醇干扰素α-2a联合利巴韦林用于治疗HIV感染患者的慢性丙型肝炎病毒感染
N Engl J Med. 2004 Jul 29;351(5):438-50. doi: 10.1056/NEJMoa040842.

引用本文的文献

1
Efficacy and safety of elbasvir/grazoprevir treatment for Chinese patients with hepatitis C virus genotype 1b: a retrospective study.艾尔巴韦/格拉瑞韦治疗中国丙型肝炎病毒1b型患者的疗效与安全性:一项回顾性研究
Am J Transl Res. 2022 Jun 15;14(6):3995-4005. eCollection 2022.
2
Interleukin-17A and B-cell activating factor in chronic hepatitis C patients with or without asymptomatic mixed cryoglobulinemia: effects of antiviral treatment and correlations with vitamin D.伴有或不伴有无症状混合性冷球蛋白血症的丙型肝炎患者中的白细胞介素-17A和B细胞活化因子:抗病毒治疗的效果及与维生素D的相关性
Ann Gastroenterol. 2018 Nov-Dec;31(6):705-711. doi: 10.20524/aog.2018.0310. Epub 2018 Sep 14.
3
Efficacy and safety of sofosbuvir-based regimens for treatment in chronic hepatitis C genotype 1 patients with moderately impaired renal function.
索磷布韦为基础的方案治疗慢性丙型肝炎基因型 1 患者中肾功能中度受损的疗效和安全性。
Clin Mol Hepatol. 2017 Dec;23(4):316-322. doi: 10.3350/cmh.2016.0087. Epub 2017 Aug 22.
4
Ribavirin Contributes to Hepatitis C Virus Suppression by Augmenting pDC Activation and Type 1 IFN Production.利巴韦林通过增强浆细胞样树突状细胞激活和1型干扰素产生来促进丙型肝炎病毒的抑制。
PLoS One. 2015 Aug 14;10(8):e0135232. doi: 10.1371/journal.pone.0135232. eCollection 2015.
5
Patterns of hepatitis C virus RNA levels during acute infection: the InC3 study.急性感染期间丙型肝炎病毒RNA水平模式:InC3研究。
PLoS One. 2015 Apr 2;10(4):e0122232. doi: 10.1371/journal.pone.0122232. eCollection 2015.
6
Factors associated with hepatitis C virus RNA levels in early chronic infection: the InC3 study.早期慢性感染中与丙型肝炎病毒RNA水平相关的因素:InC3研究
J Viral Hepat. 2015 Sep;22(9):708-17. doi: 10.1111/jvh.12384. Epub 2015 Jan 8.
7
HCV RNA viral load is independent from CD4 cell count and plasma HIV RNA viral load in immunocompetent HIV-HCV co-infected patients: a 3-years follow-up study.在免疫功能正常的 HIV-HCV 合并感染患者中,HCV RNA 病毒载量与 CD4 细胞计数和血浆 HIV RNA 病毒载量无关:一项为期 3 年的随访研究。
AIDS Res Ther. 2014 Jul 29;11:21. doi: 10.1186/1742-6405-11-21. eCollection 2014.